H.R. 2868 designates Highly Pathogenic Avian Influenza (HPAI) as a high-priority research and extension area under the Food, Agriculture, Conservation, and Trade Act of 1990. It authorizes research and extension grants to land-grant colleges and universities to study HPAI, focusing on vaccines and biosecurity.
The bill lays out two main tracks: vaccine research and delivery across poultry species, including market and trade considerations, and enhanced biosecurity practices for poultry producers. It was introduced in the 119th Congress by Rep.
Sarah McBride (D-DE) and Rep. Lawler and is currently introduced in the House.
At a Glance
What It Does
Establishes a new high-priority research and extension area for HPAI under Section 1672(d) and authorizes grants to land-grant colleges to study HPAI in two tracks: vaccine research (across poultry species, formulations, delivery) and biosecurity enhancements (training, farm-level interventions, disinfection).
Who It Affects
Directly affects land-grant colleges with extension programs and poultry producers, hatcheries, and processors that would participate in biosecurity protocols and vaccine-based strategies; USDA and state agriculture agencies coordinate implementation.
Why It Matters
Sets a formal federal focus on HPAI, aiming to advance vaccines and on-farm protections while considering market access and trade implications for the poultry sector.
More articles like this one.
A weekly email with all the latest developments on this topic.
What This Bill Actually Does
The SAVE Our Poultry Act adds Highly Pathogenic Avian Influenza to the list of topics deemed high priority for federal research and extension funding. Grants would be available to land-grant colleges and universities to study HPAI, with two main aims.
First, vaccine-related work would cover efficacy across poultry species, vaccine formulations, delivery methods, and how vaccination could influence domestic and international markets and trade. Second, biosecurity would focus on improving farm-level practices, including training for producers, on-farm interventions, and new disinfection methods.
The bill specifies the mechanism in Section 1672(d) of the Food, Agriculture, Conservation, and Trade Act of 1990, but it does not provide funding amounts. Introduced in the 119th Congress by Rep.
McBride and Rep. Lawler, the bill frames a federal research and extension agenda for avian influenza without altering other ongoing authorities.
The Five Things You Need to Know
The bill adds HPAI as a high-priority research and extension area under the FAC&TA Act of 1990.
Grants may be awarded to land-grant colleges and universities to study HPAI.
Vaccine work includes cross-species efficacy, formulations, and delivery methods, plus market and trade considerations.
Biosecurity work covers training, farm-level interventions, and new disinfection methods.
No funding amounts are specified; the bill sets scope and mechanism for grant-making and activities.
Section-by-Section Breakdown
Every bill we cover gets an analysis of its key sections.
Add HPAI as a high-priority research and extension area
Section 2 adds Highly Pathogenic Avian Influenza as a high-priority research and extension area within the existing statute (Section 1672(d) of the Food, Agriculture, Conservation, and Trade Act of 1990). It authorizes research and extension grants to land-grant colleges and universities to study HPAI for two main purposes: vaccine development and biosecurity improvements. This creates a formal, prioritized pathway for federal support directed at poultry disease control and related market implications.
Vaccine research and extension scope
This subsection outlines two components: (A) vaccine-related activities, including evaluating vaccine effectiveness across poultry species, improving vaccine formulations, refining delivery mechanisms, and assessing potential implications for domestic and international poultry markets and trade access; and (B) the mechanisms to study and support vaccine-related policies and timelines across the industry. The language directs grants to support R&D and extension activities under these topics, establishing a framework for coordinated research across institutions.
Biosecurity enhancements
This subsection focuses on enhancing biosecurity procedures for poultry producers. It covers evaluating training and biosecurity practices, improving farm-level interventions, and developing new disinfection methods. The intent is to translate R&D gains into practical on-farm actions that mitigate disease spread and protect supply chains and markets.
This bill is one of many.
Codify tracks hundreds of bills on Agriculture across all five countries.
Explore Agriculture in Codify Search →Who Benefits and Who Bears the Cost
Every bill creates winners and losers. Here's who stands to gain and who bears the cost.
Who Benefits
- Land-grant colleges and universities with extension programs receive grants to conduct targeted HPAI research and outreach, enabling coordinated nationwide activity.
- Poultry producers, hatcheries, and processing facilities gain access to improved biosecurity practices and vaccine-related insights, supporting healthier flocks and more stable production.
- The broader U.S. poultry industry and associated export markets could benefit from a more robust science-based framework to manage HPAI risks and market access considerations.
- USDA and federal researchers gain a formal, prioritized agenda for HPAI work, improving interagency coordination and program focus.
Who Bears the Cost
- Federal government would bear the costs of funding the new grants and associated administrative oversight.
- Land-grant universities may incur administrative and research costs to manage and report on new grant activities.
- Poultry producers may incur costs to implement enhanced biosecurity measures and participate in training programs.
- Industry stakeholders involved in export markets could shoulder adjustment costs if vaccine-based strategies alter market access or regulatory requirements.
Key Issues
The Core Tension
Balancing a broad, proactive investment in HPAI vaccine development and biosecurity with the practical realities of funding, administration, and potential trade implications for the poultry sector.
The bill creates a clear policy mandate to elevate HPAI research and biosecurity within the federal framework, but it leaves questions about funding levels, metrics, and oversight. Without explicit appropriations in the text, the fiscal impact depends on future appropriations and program design.
The focus on vaccines and market implications raises potential trade considerations that will need coordination with foreign market rules and international health agreements. Implementers will need clear guidance on grant eligibility, reporting requirements, and evaluation criteria to ensure consistency across institutions.
Try it yourself.
Ask a question in plain English, or pick a topic below. Results in seconds.